2024年1月30日 | 31:57 mins.
Webinar Series
Your safe path through the contract jungle: CDAs, MTAs & Co. | Coffee Break Life Sciences Start-ups #1
Early stage IP strategy pays off – Our experts Dr. Anja Lunze, LL.M. & Tobias Baus explained the pros and cons of IP protection, how to build a custom IP strategy with a matching IP portfolio, and why early patent protection is essential for biotech & pharma start-ups.
Life science technologies will require a substantial amount of (external) financing to be successful. Our leading VC experts will help you navigate the funding process and avoid unnecessary pitfalls in negotiations with investors.
本系列内容
Would you like to receive future invitations to our webinar series?
Then sign up for our mailing list.